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insulin and growth hormone granules continue to be produced in the absence of PICK1 and ICA69, albeit at diminished levels. 3, 4 Hence, we speculate that additional BARdomain-containing proteins contribute to the biogenesis of secretory granules. In fact, arfaptin-1 participates in ADP-ribosylation factor (ARF)-mediated scission of membranes associated with ISGs. 5 Here, the functions of the PICK1-ICA69 heterodimer and arfaptin-1 might be coupled, analogous to the coopera tive roles of BAR-domain-containing proteins in membrane scission mediated by the GTPase dynamin. 8 Moreover, exocrine cell types produce high levels of secretory granules, even though they seem to express neither PICK1 nor ICA69. 3 Thus, we suggest that still other BAR-domain-containing proteins contribute to the biogenesis of secretory granules in multiple organ systems.
In vitro, PICK1 promotes the formation of membrane tubules, 4 which raises the question of whether PICK1-ICA69 heterodimers really drive the budding of ISGs from the trans-Golgi network. Alternatively, PICK1 and ICA69 might participate in form ing tubular extensions or promote scission during the process of removing unwanted membrane from ISGs during their forma tion (Figure 1b) . Furthermore, as the ISG maturation process con tinues in the peripheral cytoplasm, it seems to shift to utilizing PICK1 homodimers rather than PICK1-ICA69 hetero dimers, 3 culminating in mature storage granules that contain neither PICK1 nor ICA69. Thus, in β cells, growth-hormone-secreting cells and other neuro endocrine cell types, interactions of the BAR domain of PICK1 with membranes might facilitate the removal of unwanted membrane components from ISGs in a specific order or for different purposes. For example, PICK1 also contains a PDZ domain that is able to bind various membrane protein cargo, thereby regulating the trafficking and distribution of selected re ceptors and transporters. 3 PICK1 and ICA69 have previously been implicated in human disease; a homo zygous missense mutation in PICK1 has been linked to globozoospermia (a rare form of male infer tility), 9 and ICA69 is involved in the develop ment of type 1 diabetes mel litus. 10 The nuanced phenotype of organisms with PICK1 mutations is not only because heterozygotes seem normal; 9 a complete Pick1 knock out mouse shows no defect in regulated exocytosis, and insulin secretion stimulated by glucose seems to be unchanged when normalized to intracellular insulin storage. 3 How ever, the total insulin content of islets is diminished, with apparent en richment of immature secretory organelles. 3 If endocrine feedback and the size and number of β cells remain intact (as in Pick1 knock out mice 3 ), then formation of new secret ory granules to compensate for the secretory defect will be persistently stimulated, which is a process entirely secon dary to the defect in hormone storage. This feedback stimulation further shifts the steadystate distribution of intra cellular storage towards newly made granules with an increased proinsulin:insulin ratio, a common early phenotype seen in monogenic dia betes and type 2 diabetes mellitus. However, in con trast to other forms of diabetes mellitus that have such a compensatory response, the shift towards ISGs in PICK1 deficiency is a primary rather than a secon dary defect. The study by Holst et al. shows that the same primary defect occurs in cells that produce growth hormone and in other cell types.
Further investigations are needed to determine whether acquired defect(s) in homeostatic maintenance of mature secretory granules act at the same site(s) as the important primary defects highlighted in these new studies. If so, recovery of normal insu lin gran ule maturation and secretion through restitution of normal secretory granule biogenesis might have the potential to limit the progression of type 2 diabetes mellitus.
METABOLISM

Gut microbiota modulates diurnal secretion of glucocorticoids
M. Mahmood Hussain
A new study has identified the sophisticated communication between the gut microbiota and intestinal epithelial cells that controls diurnal variations in the secretion of corticosteroids in mice. The absence of gut bacteria disrupts this communication and contributes to hypertriglyceridaemia, hyperglycaemia and insulin resistance. Mammals are born germ-free but immediately encounter microbes that they develop a lifelong symbiotic relationship with. The gut supplies bacteria with nutrients, and the micro biota increases the digestive capacity of the gut, provides the host with essential nutrients, and protects the host against potential pathogens.
1 A critical factor in this successful mutualism is the emer gence of adaptive immunity. Bacteria express Figure 1 | Regulation of corticosterone synthesis by intestinal epithelial cells in normal and germ-free mice. Bacteria activate TLRs, which leads to low levels of Ppara. The expression of Nfil3, Arntl and Rora is high at time ZT0 in the circadian cycle. By contrast, Nr1d1 levels are low, which results in low levels of corticosterone. Under germ-free conditions, TLRs are not activated, which leads to high, sustained expression of Ppara, continuous high expression of Nr1d1 and disruption of the circadian cycle and thus increased synthesis of corticosterones. Abbreviations: ZT0, 0600 h; ZT8, 1400 h; ZT12, 1800 h.
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Circadian clock genes microbe-associated molecular patterns, which are recognized by pattern-recognition receptors such as Toll-like receptors (TLRs) by the host. This inter action activates immune-cell responses and is crucial in the development of a durable immune system and in the prevention of inflammation. Intestinal epithelial cells (IECs) are critical to provide a physical barrier between the host and the gut microbiota, as well as a doorway for communication between the two. A recent study by Mukherji et al. provides molecular insights into the microbialhost interactions that might be important in the regulation of circadian rhythms in IECs. 2 Several physiologic and behavioural activities have circadian rhythms that are controlled centrally by the supra chiasmatic nuclei (SCN) in the brain. The SCN is synchronized to daily light-dark changes by optic signals delivered by the retinohypothalamic tract. The optic signals are translated into molecular events, which result in temporal expression of the core clock genes. [3] [4] [5] Normal circadian metabolism is ensured by a rhythmic and tightly coordinated expression of genes that encode regulators and metabolic enzymes. This control requires a complex regulatory network with feedback loops and transcriptional regulators, including the proteins encoded by the core clock genes Clock and Arntl (also known as Bmal1) as well as the activator nuclear receptor ROR-α (encoded by Rora) and a repressor called NR1D1 (encoded by Nr1d1), which is also known as Rev-erbA-α. 4, 5 The circadian signals from the SCN are transmitted to other tissues via hormones and serum factors that are not well-understood. In addition to the SCN, clock genes are expressed in peripheral tissues, and their expression is probably influenced by food and body temperature. 3 Thus, as opposed to the SCN where circadian rhythms are affected mainly by the light, peripheral clock genes integrate several neuronal, hormonal, metabolic, environ mental and biochemical cues to maintain their rhythmicity. 3, 6 Glucocorticoids, such as cortisol (in humans) and corticosterone (in rodents), are steroid hormones that have a critical role in metabolism and immune regulation. Cortico sterone secretion exhibits diurnal variations and is mainly controlled by the hypothalamus-pituitary-adrenal axis. How ever, IECs have also been shown to sy nthesize corticosterones. 7 Mukherji et al. studied the effect of the gut microbiota on the circadian regulation of the secretion of corticosterone by ileal IECs in mice. 2 The gut microbiota secretes several products that affect the physiology of IECs, for example, by helping with the differen tiation and proliferation of epithelial cells. 1 Mukherji and colleagues show that the interaction between bac terial product s and TLRs expressed on IECs results in decreased expression of peroxisome proliferator-activated receptor α (PPAR-α), which is encoded by Ppara (Figure 1 ). Hence, under normal conditions, the expres sion of Ppara in IECs is low. However, when mice are treated with antimicrobial agents or kept in germ-free conditions, TLRs are not activated by bacterial products, which results in increased expression of Ppara. Increased levels of PPAR-α interfere with the normal circadian regulation of corticosterone synthesis by the IECs by increasing the expression of NR1D1. When levels of NR1D1 are high, this repressor reduces the expression of the gene encoding nuclear factor interleukin-3-regulated protein (Nfil3; also known as E4bp4). Low levels of Nfil3 result in increased and sustained synthesis of c orticosterone throughout the day.
A sustained increased secretion of corticosterone affects metabolism and contri butes to hyperglycaemia, hyper triglyceridaemia, insulin resistance and high levels of fatty acids, which are seen in mice chronically treated with antibiotics or kept in a germ-free environment.
2 Constant low expression of Rora and high expression of Nr1d1 in germfree mice leads to a continuous low concentration of Arntl, which in turn di srupts the circadian rhythms. The study by Mukherji and co-workers opens up several novel questions. The authors discuss that noncircadian production of bacterial products could transmit their signal because of circadian expression of receptors such as TLRs. Secretion of bacterial products might also be rhythmic; after all, bacteria in the intestine are exposed to food in a rhythmic manner just like IECs. This theory can be tested by assessing changes in the bacterial populations or concentrations of bacterial pro ducts in the intestinal lumen after providing animals with food only for short periods of time over several days.
IECs consist of several types of differentiated cells, such as enterocytes, goblet cells
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and enteroendocrine cells. Further studies could investigate which type of cells respond to the bacterial products and produce cortico sterones. Another question to address is how the IECs respond to bacterial products when circadian rhythms are disrupted by factors such as sleep deprivation, jetlag or a high-fat diet. Furthermore, how corticosterone produced by ileal IECs only affects the ileum but not the colon is unclear. Yet, deregulation of cortico sterone synthesis by IECs affects whole-body metabolism, which causes hyper triglyceridaemia, insulin resistance and hyperglycaemia. It will be interesting to see whether agents that re-synchronize production of corticosterone by IECs could be used to treat diabetes mellitus. Pregnancy is a time of numerous changes that can alter a woman's physiology drastically. In certain circumstances, system adaptations during pregnancy can reveal or lead to pathophysiological conditions. These changes can be transitory and as such are termed gestational. Examples include gestational dia betes mellitus, which has been linked directly to increased insulin resistance, and gestational hyper tension, which has been linked to increased cardiac output with upregulation of the reninangiotensin-aldosterone system. 1 In some cases, these conditions are diagnosed during pregnancy and persist after delivery. Further more, complications occurring during pregnancy increase the risk for subsequent disease, years after delivery. Gestational diabetes mellitus is a known risk factor for sub sequent development of diabetes mellitus, and gestational h ypertension is a risk factor for chronic hypertension. Feig and co-workers now provide evidence that pre-eclampsia and gestational hyper tension also substantially increase a woman's risk of developing diabetes mellitus years after pregnancy. 2 A number of studies have described an association between complications during pregnancy and the development of metabolic diseases later in life. Obstetric complications, such as preterm birth, stillbirth and intrauterine growth restriction, have been linked to the development of long-term metabolic and cardiovascular disorders in women after delivery, including insulin resistance and type 2 diabetes mellitus. [2] [3] [4] Women with pre-eclampsia, especially when it is severe or associated with preterm delivery (<37 weeks), have an increased risk of developing other metabolic abnormalities years after pregnancy. 5 Furthermore, hypertension during pregnancy, both gestational hypertension and pre-eclampsia, has been linked to a subsequent increased risk of renal insufficiency, cardio vascular disease, heart failure and death from m yocardial infarction. 6 Feig and colleagues provide compelling evidence that pre-eclampsia and gestational hypertension are associated with the development of diabetes mellitus in women years after delivery. Women aged 15-50 years who had given birth in a hospital in Ontario, Canada, between 1994 and 2008 were included in the study. Prenatal records were linked to numerous databases to ascertain age, chronic medical conditions, and exclude women who had pregestational diabetes mellitus. The Ontario Hypertension Database was crosschecked to distinguish between cases of gestational hypertension and cases of chronic hypertension before pregnancy. Participants with pre-eclampsia were stratified on the basis of premature delivery as an indication of severe pre-eclampsia.
Over a million women (1,010,068) were followed up from 180 days postpartum to up to 16 years after pregnancy (median follow up 8.5 years after delivery). In the cohort, the researchers identified 22,933 cases of preeclampsia, 27,605 cases of gestational hypertension, 30,852 cases of gestational dia betes mellitus, 2,100 cases of gesta tional dia betes mellitus and gestational hyper tension, and 1,476 cases of gestational diabetes mellitus and pre-eclampsia. The main outcome measure was a new diagnosis of diabetes mellitus during follow-up. In multi variable analy ses, this outcome was much more prevalent in women with gestational diabetes mellitus alone than in those without the condition (HR 12.77). The simulta neous presence of gestational hypertension or pre-eclampsia further increased the risk of
